Neuroendocrinology

Featured

Acromegaly

Acromegaly is a serious endocrine condition resulting from an excess of growth hormone (GH) in the blood. GH is released by the pituitary gland and is carried through the rest of the body where it has specific effects.

Latest

Acromegaly Diagnosis Delayed in Elderly Woman

Acromegaly Diagnosis Delayed in Elderly Woman

The presence of a pituitary tumor on magnetic resonance imaging confirmed the diagnostic hypothesis.

FDA Approves FlexPro PenMate for Norditropin Users

FDA Approves FlexPro PenMate for Norditropin Users

The FDA has approved the FlexPro PenMate is intended for users of Norditropin, which is indicated for patients with growth hormone-related disorders, who prefer hidden needles during injection.

Surgeon Volume Associated With Costs in Pituitary Tumor Care

Surgeon Volume Associated With Costs in Pituitary Tumor Care

Results show increased hospital charges, costs and length of stay for patients treated by lower-volume surgeons.

Copeptin May Be Marker for Diabetes Insipidus After Pituitary Surgery

Copeptin May Be Marker for Diabetes Insipidus After Pituitary Surgery

Copeptin represents a novel, early marker for postoperative diabetes insipidus after pituitary surgery.

Signifor Earns FDA Approval for Acromegaly

Signifor Earns FDA Approval for Acromegaly

The FDA has approved pasireotide (Signifor long-acting release) for treatment of acromegaly.

Endocrine Society Releases Guidelines for Acromegaly

Endocrine Society Releases Guidelines for Acromegaly

The Endocrine Society has issued a clinical practice guideline for the diagnosis and treatment of acromegaly.

Growth Hormone Linked to Increased Cardiovascular Risks

Growth Hormone Linked to Increased Cardiovascular Risks

Cardiovascular morbidity and mortality may be increased in people with higher values of fasting growth hormone.

Growth Hormone Replacement Improves Long-Term Quality of Life in Growth Hormone Deficiency

Growth Hormone Replacement Improves Long-Term Quality of Life in Growth Hormone Deficiency

Patients with growth hormone deficiency reaped significant benefits in quality of live over the long term.

Study Suggests Proton Beam Therapy Effective for Functional Pituitary Adenomas

Study Suggests Proton Beam Therapy Effective for Functional Pituitary Adenomas

Proton irradiation is an effective treatment for functional pituitary adenomas, and hypopituitarism remains the primary adverse effect.

ATL1103 Decreases IGF-1 in Acromegaly Trial

ATL1103 Decreases IGF-1 in Acromegaly Trial

In patients with acromegaly, ATL1103 significantly reduced serum insulin-like growth factor I (IGF-1) after 14 weeks of treatment.

Sign Up for Free e-Newsletters

CME Focus